- Clinical characteristics and laboratory results of the control and Covid-19 cohorts.
Characteristics | Controls (n=250) median (95% CI) | COVID-19 cases (n=701) median (95% CI) | P-value |
---|---|---|---|
Gender, n (%) | |||
Male Female | 138 (55.2) 112 (44.8) | 317 (45.2) 384 (54.8) | 0.0079* |
Age (years) | 48 (44.58-48.13) | 35 (35.09-37.77) | <0.0001* |
Red blood cell x106/L | 5.08 (5.02-5.11) | 4.75 (4.65-4.78) | <0.0001* |
Hemoglobin g/dL | 14 (13.6-14.06) | 13.2 (11.79-12.52) | <0.0001* |
Mean corpuscular volume fL | 90.35 (88.74-90.8) | 86.35 (84.98-86.33) | <0.0001* |
Mean corpuscular hemoglobin pg | 29.55 (29.28-29.69) | 28.7 (27.96-28.49) | <0.0001* |
Mean corpuscular hemoglobin concentration g/dL | 33 (32.91-33.14) | 33 (32.51-33.02) | 0.63 |
Platelet count x103/μl | 309.5 (297.5-320.7) | 231.5 (242.2-260.8) | <0.0001* |
White blood cell count x103/μl | 7.2 (6.92-7.37) | 5.5 (6.12-6.83) | <0.0001* |
Neutrophil count x103/μl | 4.4 (4.28-4.64) | 3.48 (4.09-4.75) | <0.0001* |
Neutrophil percentage | 58 (56.03-58.6) | 66.8 (63.35-66.47) | <0.0001* |
Lymphocyte count x103/μl | 2.1 (1.95-2.1) | 0.9 (0.9-1.31) | <0.0001* |
Lymphocyte percentage | 30.45 (29.8-31.31) | 22.6 (22.88-25.61) | <0.0001* |
Monocyte count x103/μl | 0.6 (0.61-0.69) | 0.33 (0.33-0.61) | <0.0001* |
Neutrophil-to-lymphocyte ratio | 2.18 (2.3-2.6) | 2.9 (4.24-5.31) | <0.0001* |
The table demonstrates the clinical characteristics and the complete blood results of both the control and patients’cohorts.
Laboratory results are stated as median values with 95% confidence intervals between brackets, unless stated otherwise.
↵*Statistical significance. CI: confidence intervals